معرفی
Uwe Ackermann serves as an Adjunct Associate Professor at La Trobe University's School of Cancer Medicine, specializing in radiopharmaceutical development and molecular imaging for oncology applications. His research focuses on creating novel PET tracers for cancer diagnostics and theranostics, with emphasis on prostate and breast cancers, neuroinflammation, and epigenetic targets.
His research interests span Radiopharmaceuticals, Molecular Imaging, and Cancer Therapeutics, particularly in developing fluorine-18 and zirconium-89 labeled tracers for estrogen receptor imaging, PSMA-targeted prostate cancer therapy, MERTK visualization in neuroinflammation, and BET protein-targeted tumor imaging. Recent work demonstrates expertise in automated radiosynthesis, translational validation, and clinical trial implementation.
Awarded a National Health and Medical Research Council (NHMRC) Project Grant (2018-2020) for 'Alpha Particle Therapy of Solid Tumours', his funded research bridges preclinical development and clinical application. While no formal students are listed in available records, his collaborative network includes major cancer research institutions across Australia.
Key laboratory work occurs through partnerships with Austin Health and La Trobe University's imaging facilities, focusing on GMP-compliant radiopharmaceutical production and multi-center clinical trials. Current projects emphasize theranostic approaches combining diagnostic imaging with targeted radionuclide therapy.
